Eyal S. Ron Email & Phone Number
Who is Eyal S. Ron? Overview
A concise factual answer block for searchers comparing this professional profile.
Eyal S. Ron is listed as Co-Founder and Partner at SBH BioVenture, based in Greater Boston, United States, United States. AeroLeads shows a matched LinkedIn profile for Eyal S. Ron.
Eyal S. Ron previously worked as Board Member at Endocure and Chairperson of the Board at Amacathera.
Email format at SBH BioVenture
This section adds company-level context without repeating Eyal S. Ron's masked contact details.
Review company-level records connected to Eyal S. Ron before choosing the right outreach path.
About Eyal S. Ron
Dr. Eyal S. Ron is a seasoned serial entrepreneur and strategic advisor with over 30 years of experience in drug development, medical devices, cosmeceuticals, and nutraceuticals. He excels in guiding start-ups from inception to exit, combining scientific expertise with business acumen. Renowned for being an exceptional out-of-the-box thinker and solution provider, Dr. Ron is adept at helping organizations redefine their agile strategies, transforming decision-making and empowering teams to deliver value early and effectively. Dr. Ron serves on multiple corporate boards, offering strategic guidance while mentoring emerging entrepreneurs. His expertise and mentorship make him a valuable asset to any organization in the life sciences and medical innovation sectors.
Eyal S. Ron's current company
Company context helps verify the profile and gives searchers a useful next step.
Eyal S. Ron work experience
A career timeline built from the work history available for this profile.
Board Member
CurrentEndocure is a Femtech company that is revolutionizing endometriosis diagnostics and treatment planning with a novel robotic AI-powered ultrasound. Their technology provides more accurate and timely diagnosis of endometriosis, as well as personalized treatment plans for each patient.
Chairperson Of The Board
CurrentAmacaThera is a pioneering biotechnology company revolutionizing drug delivery with its innovative platform, AmacaGel™. The company focuses on developing long-acting, cost-effective therapies for cancer and non-opioid analgesic applications, aiming to enhance patient outcomes and address critical unmet medical needs.
Executive Board Member And Co-Founder
CurrentKeyron is aiming to reverse Diabesity. Keyron’s Forepass™ replicates Roux-en-Y Gastric Bypass (RYGB) gastric bypass surgery without the surgery. It’s the first device that can reverse diabetes.
Chief Technology Officer & Co-Founder
CurrentLiliger has developed a science-based line of cosmeceuticals, which renews the skin while simultaneously extends the effects of cosmetic treatments for maintaining a young & radiant appearance for an extended period.
Chief Technology Officer
CurrentPolyrizon is a pioneering biotech company dedicated to the development and commercialization of innovative intranasal products. With a focus on transforming drug delivery and improving patient outcomes, Polyrizon is shaping the future of biotech solutions.
Executive Board Member And Co-Founder
CurrentPrinting Organs - Printing LifeRECMA Bio is taking organ regeneration to the next level. We are combining biomaterial sciences, tissue engineering, 3D bioprinting, and robotics, to develop a robotic system for in-situ bioprinting, harnessing the body's natural abilities to regenerate and heal.
Managing Partner
CurrentMentor, Professional Director, Adviser and Serial Entrepreneur.
Principal
CurrentMADASH, LLC is a consulting company founded and managed by Dr. Eyal S. Ron. MADASH supports Pharmaceutical, Biotechnology, Cosmeceutical and Nutraceutical companies to advance their product candidates rapidly and cost-efficiently from R&D to commercialization. MADASH’s support enhances the corporate value by providing expertise and out of the box creative.
Founder And Principal
CurrentNovel Smart Biomaterials for consumer products, cosmetics and pharmaceutical applications
Member
CurrentA Boston-based investment group that provides funding to early-stage life science and healthcare companies. The Sky Ventures Group angel investors want to change the early stage investment landscape and impact lives by building outstanding life science & healthcare companies.
Board Member
Advisor / Mentor
A FemTech that provides the first sustainable makeup line that supports fertility and pregnancy. The company's goal is to empower women with the knowledge to select safer cosmetics during a critical time of their lives without compromising beauty.
Advisor
Generation-Tested, Family Approved Remedies For Your Skin Sensitive Family® carefully curated from around the globe! Traditional remedies passed down for generations reformulated with the help of modern technology for the whole family.
Board Member
AcousticaBio's unique technology, patented by Harvard, transforms microscale fluid processing and is exceptionally effective for handling monoclonal antibodies. This technology surpasses the constraints of existing manufacturing processes. Targeting its initial market, AcousticaBio is focused on converting biologic products currently administered.
Member Of The Board Of Advisors
Member Board Of Directors
PharMedica develops innovative polymer-based delivery platforms for controlled drug release, including patented orally dissolving films (ODFs) for needle-free, enhanced bioavailability. Their lead product, iCling™ for Dry Mouth, is commercially available. Learn more: pharmedica.co.il
Executive Board Member
A medical device startup, developing novel tools for selectively treat viral infections by laser-induced shockwave.
Member Board Of Directors
AcuityBio Inc., was a developer of novel drug-delivery combination products to treat various types of early stage soft tissue cancers. AcuityBio was acquired (2021) by Cook Biotech, a leader in advanced biomaterials and regenerative medicines.
Co Founder
A market leader in highly efficacious, science-backed beauty products based on human physiology(TM). The innovator of the Anti-Aging Skin Fitness Program.
Cto (And Co-Founder)
www.gelesis.comGelesis' first commercial product, Plenity(TM), is a first-of-its kind smart pill which is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger, resulting in reduced caloric intake and weight loss. Plenity is indicated to aid in weight management in overweight and obese adults with a Body.
Cto (And Co-Founder)
Palmetto Pharmaceuticals is a drug development company specializing in combination therapies aimed at improving endothelial function, enhancing blood flow, and reducing triglycerides through the synergistic effects. Their nutraceutical product, L-Arginine Sustained Release (formerly Perfusia-SR), supports heart function, nitric oxide production, and.
Chief Technology Officer And Founder
A women’s healthcare company specializing in transvaginal drug delivery technology, successfully licensed to Dare Bioscience (darebioscience.com).
Chief Technology Officer
Polyrizon Ltd. is a Health Care seed-stage Company that develops novel biological-gels based on its novel Capture and Contain (C&C) platform technology. The C&C technology, with its unique specificity capabilities, can be readily adapted for a wide range of applications to protect human body from pathogens such as pollen, viruses, bacterium and more.
Coo
Oxford Pharmaceutical Services specializing in the distributionof drugs to the health care community. Under leadership the company purchased the rights to Marplan form ROCHE and sold it profitably to Validus Pharmaceuticals
Senior Director Of Formulation Development
http://www.neurohealing.comNeuroHealing is a clinical stage biopharmaceutical company developing innovative drug treatments for specialty indications based on neurologically active compounds.
Cto / Coo And Founder
GelMed was an innovator of transmucosal drug delivery. Under leadership the company developed 2 proprietary platforms that were successfully tested in Phase 2 clinical studies. The company was sold successfully.
Founder, Coo, Cso
GelMed was an innovator of SmartHydrogel(R) Transmucosal drug delivery. Under leadership the company developed 2 proprietary platforms that were successfully tested in Phase 2a clinical studies. The company was sold successfully.
Director Of Pharmaceutical Development
Director
Co-innovator of the Infuse® Spine Fusion product, a groundbreaking advancement in spinal surgery.
Principal Investigator
Post Doc
Frequently asked questions about Eyal S. Ron
Quick answers generated from the profile data available on this page.
What company does Eyal S. Ron work for?
Eyal S. Ron works for SBH BioVenture.
What is Eyal S. Ron's role at SBH BioVenture?
Eyal S. Ron is listed as Co-Founder and Partner at SBH BioVenture.
Where is Eyal S. Ron based?
Eyal S. Ron is based in Greater Boston, United States, United States while working with SBH BioVenture.
What companies has Eyal S. Ron worked for?
Eyal S. Ron has worked for Sbh Bioventure, Endocure, Amacathera, Keyron, and Liliger Ltd.
How can I contact Eyal S. Ron?
You can use AeroLeads to view verified contact signals for Eyal S. Ron at SBH BioVenture, including work email, phone, and LinkedIn data when available.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial